PRESS RELEASES

Strawn Arnold & Associates, Ltd. Adds Jeff Frazier as an Executive Vice President

AUSTIN, TEXAS, May 14, 2018 – Strawn Arnold & Associates (SAA), a premier provider of executive search to the healthcare and life science industries, is pleased to announce the appointment of industry veteran Jeff Frazier as Executive Vice President. Jeff has a tremendous background as a senior Human Resources leader, with almost 30 years of pharmaceutical industry experience in Europe and the United States.

“As we at SAA continue to grow and meet demand, we remain dedicated to our business model, which relies on former industry executives who enter search with the experience necessary to fully relate to the client and their needs”, says John Groover, Managing Director. “Having executives such as Jeff who choose search as a second career, and are also committed to conducting the search process in a non-leveraged model, are the backbone of our business and our continued success.”

Prior to joining SAA, Jeff was The Medicines Company (MDCO) Executive Vice President and Chief Human Strategy Officer from June 2014. During his tenure, he was an officer and member of the Executive Management team that lead the business transformation from an 800 person organization with multiple “in market”, hospital sector products to a development stage company of 60 people focused exclusively on Inclisiran, an important cardio vascular product in late stage development. Three distinct divestitures were executed from 2016-2018, which generated $1 billion in non-dilutive capital plus the potential of an additional $1 billion in milestone payments. This capital infusion was required to complete phase III trials and bring Inclisiran to NDA filing. Inclisiran, is an investigational agent which is potentially a first-in-class lipid-lowering drug, to reduce LDL-cholesterol. The Medicines Company is a publicly traded biopharmaceutical company with market capitalization of around $2.8 billion.

Prior to joining MDCO, Jeff was the Corporate Vice President of Human Resources and Public Affairs at Novo Nordisk Inc. from 2004 to 2014. His leadership resulted in Novo Nordisk being named the number one “Best Place to Work” in New Jersey for four out of six years (2004 – 2010), and in being named to the Fortune Magazine “100 Best Companies to Work For” for six consecutive years (2009-2014).

Before taking his position at Novo Nordisk, Jeff was Head of Human Resources for Pharmacia Corporation’s Global Pharmaceutical Business unit, where he served as a member of the global commercial leadership team. There he supported international commercial operations of 12,500 employees in 50 countries, through the design and execution of human resources strategy and programs. Prior to that role, he held a number of different senior human resources positions in Europe and in the USA. Jeff received a bachelor’s degree in business administration from Kent State University.